Objectives: To define the value of mastoidectomy in cases of malignant otitis externa.
Study design: Case Series.
Patients and Methods: Study of Patients with malignant otitis externa (MOE) treated by mastoidectomy from Jan 2016 to October 2018 and followed up clinically, laboratory and radiologically.
Results: Postsurgical siginifacant resolution of symptoms and regression of the disease. Otalgia showed siginificant decrease by assessment with Visual Analogue Score. Also there are improvement of otorrhea, decrease of the reactive indicators as Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and radiological improvement of osteomyelitis in Computed Tomography and technetium-99m methylene diphosphonate (MDP) and gallium-67 citrate scintigraphy.
Conclusion: In patients with MOE, resistant to medical treatment and have evidence of mastoiditis and Middle ear affection, cortical mastoidectomy may be the treatment for both symptom relieve and regression of the disease